Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Barbui

Showing results (141-150 of 380) with videos related to

Pageof 38
Sort By:
Leukemia|November 27, 2014
The rate of transformation from JAK2-mutated ET to PV is influenced by an accurate WHO-defined clinico-morphological diagnosisT Barbui, J Thiele, A Carobbio, et al.
Thrombosis Research|July 1, 1985
Normal vascular prostacyclin generation in patients with chronic myeloproliferative disordersS Cortelazzo, P Viero, C Morelli, et al.
Thrombosis and Haemostasis|March 1, 1997
Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodiesM Galli, G Beretta, M Daldossi, et al.
Leukemia & Lymphoma|September 1, 1996
Treatment strategies in essential thrombocythemia. A critical appraisal of various experiences in different centersT Barbui, G Finazzi, E Dupuy, et al.
Leukemia|November 9, 2000
Trends in mortality from leukemia in subsequent age groupsF Levi, F Lucchini, E Negri, et al.
Scandinavian Journal of Haematology|February 1, 1985
Platelet 5-hydroxytryptamine transport and storage in myeloproliferative disordersS Cortellazzo, P Viero, W Buczko, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1986
Platelet dysfunction in splenectomized patients with hairy cell leukemiaS Cortelazzo, P Viero, A D'Emilio, et al.
Leukemia|August 1, 1993
Modulation of cell proliferation and cytokine production in AML by recombinant interleukin-1 receptor antagonistA Rambaldi, M Torcia, C A Dinarello, et al.
The American Journal of Medicine|August 1, 1987
Aspirin and risk of bleeding in patients with thrombocythemiaT Barbui, M Buelli, S Cortelazzo, et al.
Haematologica|January 1, 1973
[Siderinuria caused by deferoxamine. II. The siderinuric increment obtained by association with ascorbic acid]G Cartei, T Chisesi, M Cazzavillan, et al.
Pageof 38

Showing results (141-150 of 380) with videos related to

Sort By:
Pageof 38
Leukemia|November 27, 2014
The rate of transformation from JAK2-mutated ET to PV is influenced by an accurate WHO-defined clinico-morphological diagnosisT Barbui, J Thiele, A Carobbio, et al.
Thrombosis Research|July 1, 1985
Normal vascular prostacyclin generation in patients with chronic myeloproliferative disordersS Cortelazzo, P Viero, C Morelli, et al.
Thrombosis and Haemostasis|March 1, 1997
Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodiesM Galli, G Beretta, M Daldossi, et al.
Leukemia & Lymphoma|September 1, 1996
Treatment strategies in essential thrombocythemia. A critical appraisal of various experiences in different centersT Barbui, G Finazzi, E Dupuy, et al.
Leukemia|November 9, 2000
Trends in mortality from leukemia in subsequent age groupsF Levi, F Lucchini, E Negri, et al.
Scandinavian Journal of Haematology|February 1, 1985
Platelet 5-hydroxytryptamine transport and storage in myeloproliferative disordersS Cortellazzo, P Viero, W Buczko, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1986
Platelet dysfunction in splenectomized patients with hairy cell leukemiaS Cortelazzo, P Viero, A D'Emilio, et al.
Leukemia|August 1, 1993
Modulation of cell proliferation and cytokine production in AML by recombinant interleukin-1 receptor antagonistA Rambaldi, M Torcia, C A Dinarello, et al.
The American Journal of Medicine|August 1, 1987
Aspirin and risk of bleeding in patients with thrombocythemiaT Barbui, M Buelli, S Cortelazzo, et al.
Haematologica|January 1, 1973
[Siderinuria caused by deferoxamine. II. The siderinuric increment obtained by association with ascorbic acid]G Cartei, T Chisesi, M Cazzavillan, et al.
Pageof 38